Dr. Marc Swanson, MD

Pain Medicine Salem, VA Male
NPI: 1255350831
Total Payments
$11,941
2023 Payments
$1,297
Companies
53
Transactions
604
Medicare Patients
10,807
Medicare Billing
$1.5M

Payment Breakdown by Category

Food & Beverage$11,923 (99.8%)
Education$18.00 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $11,923 601 99.8%
Education $18.00 3 0.2%

Top Paying Companies

Company Total Records Latest Year
Medtronic USA, Inc. $3,835 151 $0 (2020)
Medtronic, Inc. $2,365 56 $0 (2023)
Daiichi Sankyo Inc. $877.10 63 $0 (2019)
Collegium Pharmaceutical, Inc. $818.37 80 $0 (2023)
AbbVie Inc. $664.71 55 $0 (2023)
Teva Pharmaceuticals USA, Inc. $262.74 10 $0 (2019)
Amgen Inc. $256.05 11 $0 (2022)
AstraZeneca Pharmaceuticals LP $234.55 13 $0 (2018)
DePuy Synthes Sales Inc. $218.30 14 $0 (2023)
Novartis Pharmaceuticals Corporation $212.86 11 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2023 $1,297 58 Medtronic, Inc. ($828.87)
2022 $1,362 73 Medtronic, Inc. ($717.33)
2021 $1,594 65 Medtronic, Inc. ($818.45)
2020 $1,437 71 Medtronic USA, Inc. ($1,052)
2019 $1,856 79 Medtronic USA, Inc. ($996.56)
2018 $2,067 116 Medtronic USA, Inc. ($864.52)
2017 $2,328 142 Medtronic USA, Inc. ($921.94)

All Payment Transactions

604 individual payment records from CMS Open Payments — Page 1 of 25

Date Company Product Nature Form Amount Type
12/19/2023 AbbVie Inc. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $4.03 General
Category: NEUROSCIENCE
12/12/2023 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $14.72 General
Category: NEUROSCIENCE
12/07/2023 Medtronic, Inc. VANTA ADAPTIVESTIM (Device) Food and Beverage In-kind items and services $36.21 General
Category: Spinal Cord Neurostimulation
12/05/2023 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $14.27 General
Category: Opioid Analgesic
11/29/2023 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $11.85 General
Category: Opioid Analgesic
11/28/2023 AbbVie Inc. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $15.23 General
Category: NEUROSCIENCE
11/08/2023 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $9.81 General
Category: NEUROSCIENCE
10/31/2023 Medtronic, Inc. ACCURIAN (Device) Food and Beverage In-kind items and services $18.07 General
Category: Neuro Pain (includes Interventional)
10/18/2023 AbbVie Inc. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $1.96 General
Category: NEUROSCIENCE
10/11/2023 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $14.34 General
Category: Opioid Analgesic
10/02/2023 Medtronic, Inc. INTELLIS ADAPTIVESTIM (Device) Food and Beverage In-kind items and services $9.43 General
Category: Spinal Cord Neurostimulation
09/27/2023 DePuy Synthes Sales Inc. MONOVISC (Device) Food and Beverage In-kind items and services $20.25 General
Category: Sports Early Intervention
09/12/2023 Medtronic, Inc. VANTA ADAPTIVESTIM (Device) Food and Beverage In-kind items and services $10.39 General
Category: Spinal Cord Neurostimulation
08/30/2023 DePuy Synthes Sales Inc. MONOVISC (Device) Food and Beverage In-kind items and services $14.46 General
Category: Sports Early Intervention
08/30/2023 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $13.99 General
Category: Opioid Analgesic
08/30/2023 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $2.66 General
Category: Opioid Analgesic
08/29/2023 AbbVie Inc. QULIPTA (Drug) Food and Beverage In-kind items and services $10.62 General
Category: NEUROSCIENCE
08/23/2023 AbbVie Inc. QULIPTA (Drug) Food and Beverage In-kind items and services $22.32 General
Category: NEUROSCIENCE
08/23/2023 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $11.68 General
Category: Opioid Analgesic
08/10/2023 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $7.51 General
Category: NEUROSCIENCE
08/09/2023 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $5.19 General
Category: NEUROSCIENCE
07/25/2023 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $14.46 General
Category: Opioid Analgesic
07/25/2023 AbbVie Inc. QULIPTA (Drug) Food and Beverage In-kind items and services $10.93 General
Category: NEUROSCIENCE
07/12/2023 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $15.78 General
Category: Opioid Analgesic
07/12/2023 AbbVie Inc. BOTOX (Biological) Food and Beverage In-kind items and services $15.55 General
Category: BOTOX THERAPEUTIC
123…25»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 18 2,360 3,904 $622,014 $322,369
2022 15 2,042 3,278 $787,241 $284,947
2021 21 3,969 6,211 $1.8M $567,402
2020 26 2,436 6,427 $1.1M $337,922
Total Patients
10,807
Total Services
19,820
Medicare Billing
$1.5M
Procedure Codes
80

All Medicare Procedures & Services

80 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 510 1,298 $316,712 $107,721 34.0%
80307 Testing for presence of drug, by chemistry analyzers Office 2023 740 936 $74,880 $55,935 74.7%
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2023 398 464 $58,000 $51,298 88.4%
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2023 250 322 $57,960 $48,003 82.8%
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2023 71 71 $19,880 $17,181 86.4%
62323 Injection of substance into lower spine canal using imaging guidance Office 2023 33 55 $26,730 $11,056 41.4%
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2023 37 45 $9,450 $8,405 88.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 62 81 $14,094 $5,173 36.7%
62370 Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician Office 2023 20 44 $7,744 $3,011 38.9%
77002 Fluoroscopic guidance for needle placement Office 2023 19 31 $6,634 $2,863 43.2%
20610 Aspiration and/or injection of fluid from large joint Office 2023 27 48 $6,880 $2,498 36.3%
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 11 48 $5,856 $2,346 40.1%
J7999 Compounded drug, not otherwise classified Office 2023 16 40 $4,495 $1,856 41.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 20 20 $4,320 $1,755 40.6%
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg Office 2023 83 262 $3,070 $1,354 44.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 11 11 $3,542 $1,225 34.6%
20553 Injection of trigger points, 3 or more muscles Office 2023 12 14 $1,652 $650.72 39.4%
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml Office 2023 40 114 $115.00 $38.72 33.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 439 1,153 $245,674 $102,286 41.6%
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2022 278 345 $143,418 $51,226 35.7%
80307 Testing for presence of drug, by chemistry analyzers Office 2022 660 801 $164,750 $47,784 29.0%
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2022 314 341 $101,210 $37,810 37.4%
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2022 41 41 $26,592 $9,983 37.5%
62323 Injection of substance into lower spine canal using imaging guidance Office 2022 26 44 $33,779 $9,251 27.4%
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms Office 2022 34 43 $23,489 $8,238 35.1%
1234»

About Dr. Marc Swanson, MD

Dr. Marc Swanson, MD is a Pain Medicine healthcare provider based in Salem, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255350831.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marc Swanson, MD has received a total of $11,941 in payments from pharmaceutical and medical device companies, with $1,297 received in 2023. These payments were reported across 604 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($11,923).

As a Medicare-enrolled provider, Swanson has provided services to 10,807 Medicare beneficiaries, totaling 19,820 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.

Practice Information

  • Specialty Pain Medicine
  • Other Specialties Anesthesiology
  • Location Salem, VA
  • Active Since 07/18/2006
  • Last Updated 05/16/2024
  • Taxonomy Code 207LP2900X
  • Entity Type Individual
  • NPI Number 1255350831

Products in Payments

  • INTELLIS (Device) $1,971
  • ADAPTIVESTIM (Device) $1,165
  • INTELLIS ADAPTIVESTIM (Device) $490.56
  • Movantik (Drug) $472.69
  • XTAMPZA (Drug) $417.75
  • Morphabond ER (Drug) $404.41
  • UBRELVY (Drug) $387.12
  • PISCES (Device) $385.11
  • ACCURIAN (Device) $375.51
  • VANTA ADAPTIVESTIM (Device) $362.09
  • SYNCHROMED (Device) $317.28
  • Belbuca (Drug) $308.91
  • AJOVY (Drug) $262.74
  • Aimovig (Biological) $256.05
  • QULIPTA (Drug) $250.33
  • KYPHON Balloon Kyphoplasty (Device) $242.46
  • MOVANTIK (Drug) $234.55
  • MONOVISC (Device) $218.30
  • KYPHON EXPRESS II KYPHOPAK TRAY (Device) $183.90
  • Accurian (Device) $175.05

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pain Medicine Doctors in Salem

Craig Anderson, Md, MD

Pain Medicine — Payments: $46,290

Pain Medicine $46,290

George Baylor, Md, MD

Pain Medicine — Payments: $45,354

Pain Medicine $45,354

Dr. Anthony Dragovich, Md, MD

Pain Medicine — Payments: $18,359

Pain Medicine $18,359

Dr. Rebeca Monreal, Do, DO

Pain Medicine — Payments: $2,732

Pain Medicine $2,732

Cooper Beierle, Fnp-C, FNP-C

Pain Medicine — Payments: $270.54

Pain Medicine $270.54

Dr. Douglas Nemec, M.d, M.D

Pain Medicine — Payments: $42.59

Pain Medicine $42.59